NYSE raises immediate delisting price trigger to $0.25 per share
The rule, effective July 1 2027, applies to all NYSE-listed securities that trade below $0.25.
On August 14 2026 the Securities and Exchange Commission issued an order granting accelerated approval of Amendment No. 2 to the New York Stock Exchange Listed Company Manual. The amendment revises Section 802.01C, which governs price-based continued-listing standards.
The amendment raises the threshold for automatic suspension and delisting from a closing price of $0.10 to a closing price of $0.25 per share. When a security's price falls below $0.25 on any trading day, the Exchange will immediately suspend trading and commence delisting proceedings under Section 804.00. The issuer will not be eligible to use the cure procedures set out in Sections 802.01C, 802.02, or 802.03 for the new minimum-price criterion.
The existing $1.00 average-price requirement over a consecutive 30-trading-day period and the six-month cure period remain unchanged. The amendment also leaves in place the Exchange's rule limiting reverse stock splits to a cumulative ratio of 200-to-1 within any two-year period and other qualitative standards in Section 802.01D.
The rule is slated to become effective on July 1 2027, giving issuers a transition window to consider reverse splits or other actions to raise their share price. The Commission noted that no comments were received on the original filing or Amendment 1.
The order invites interested persons to submit comments on Amendment 2 before the Commission's final action.